Evolutionary Tree Capital Management, LLC Ascendis Pharma A/S Transaction History

Evolutionary Tree Capital Management, LLC

$97.2 Million
Q2 2024

A detailed history of Evolutionary Tree Capital Management, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Evolutionary Tree Capital Management, LLC holds 24,862 shares of ASND stock, worth $3.64 Million. This represents 3.49% of its overall portfolio holdings.

Number of Shares

24,862

Previous 13,639 82.29%

Holding current value

$3.64 Million

Previous $2.06 Million 64.48%

% of portfolio

3.49%

Previous 2.07%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$121.07 - $153.67 $1.36 Million - $1.72 Million	11,223 Added 82.29%	24,862 $3.39 Million
Q1 2024 May 13, 2024	SELL	$123.45 - $159.4 $381,090 - $492,067	-3,087 Reduced 18.46%	13,639 $2.06 Million
Q4 2023 Feb 13, 2024	BUY	$86.1 - $127.36 $5,940 - $8,787	69 Added 0.41%	16,726 $2.11 Million
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $25,085 - $30,151	-290 Reduced 1.71%	16,657 $1.56 Million
Q2 2023 Aug 10, 2023	BUY	$69.96 - $97.84 $440,398 - $615,902	6,295 Added 59.1%	16,947 $1.51 Million
Q1 2023 May 09, 2023	SELL	$104.9 - $126.78 $1.23 Million - $1.48 Million	-11,695 Reduced 52.33%	10,652 $1.14 Million
Q4 2022 Feb 14, 2023	SELL	$99.42 - $131.97 $675,956 - $897,264	-6,799 Reduced 23.33%	22,347 $2.73 Million
Q3 2022 Nov 10, 2022	BUY	$84.03 - $110.23 $545,102 - $715,062	6,487 Added 28.63%	29,146 $3.01 Million
Q2 2022 Aug 11, 2022	SELL	$78.08 - $117.61 $1.16 Million - $1.75 Million	-14,842 Reduced 39.58%	22,659 $2.11 Million
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $532,459 - $707,393	-5,211 Reduced 12.2%	37,501 $4.4 Million
Q4 2021 Feb 11, 2022	BUY	$127.1 - $169.66 $2.47 Million - $3.3 Million	19,470 Added 83.77%	42,712 $5.75 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $661,598 - $1.04 Million	5,872 Added 33.81%	23,242 $3.71 Million
Q2 2021 Aug 12, 2021	BUY	$121.62 - $145.29 $73,701 - $88,045	606 Added 3.61%	17,370 $2.29 Million
Q1 2021 May 14, 2021	BUY	$124.92 - $173.33 $568,635 - $788,998	4,552 Added 37.27%	16,764 $2.16 Million
Q4 2020 Feb 10, 2021	BUY	$151.2 - $182.76 $1.85 Million - $2.23 Million	12,212 New	12,212 $2.04 Million

Others Institutions Holding ASND

# of Institutions

223

Shares Held

56.5M

Call Options Held

142K

Put Options Held

259K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.18B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolutionary Tree Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolutionary Tree Capital Management, LLC with notifications on news.

Account

Evolutionary Tree Capital Management, LLC Ascendis Pharma A/S Transaction History